volume 28, issue 6, P750-754 2014
DOI: 10.3109/02688697.2014.913779
View full text
|
|
Share
Giuseppe M. V. Barbagallo, Francesco Certo, Kathrin Heiss, Vincenzo Albanese

Abstract: 5-aminolevulinic acid (5-ALA) has been used for the last 5 years to increase the extent of resection in adult brain tumors, mostly glioblastomas, but it is not approved yet as standard adjuvant treatment in the pediatric population. We report three different cases of pediatric brain tumors (two glioblastomas and one medulloblastoma) recently operated using 5-ALA fluorescence guidance, highlighting how useful it is in pediatric high-grade glioma (but not in medulloblastoma) also and confirming the lack of 5-ALA…

expand abstract